BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 66 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $613,257 | -26.0% | 42,558 | -15.7% | 0.00% | 0.0% |
| Q2 2023 | $829,232 | -8.9% | 50,501 | -7.3% | 0.00% | -50.0% |
| Q1 2023 | $910,617 | +3.3% | 54,495 | -4.6% | 0.00% | 0.0% |
| Q4 2022 | $881,655 | -1.6% | 57,139 | -4.8% | 0.00% | 0.0% |
| Q3 2022 | $896,000 | -9.9% | 60,016 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $995,000 | -52.8% | 60,571 | -42.4% | 0.00% | -33.3% |
| Q1 2022 | $2,110,000 | -27.6% | 105,185 | -8.5% | 0.00% | -25.0% |
| Q4 2021 | $2,915,000 | -3.5% | 114,953 | +2.6% | 0.00% | -20.0% |
| Q3 2021 | $3,022,000 | -5.8% | 111,991 | +0.9% | 0.01% | 0.0% |
| Q2 2021 | $3,209,000 | +2.3% | 110,957 | -7.0% | 0.01% | 0.0% |
| Q1 2021 | $3,137,000 | -3.2% | 119,281 | +5.5% | 0.01% | -16.7% |
| Q4 2020 | $3,240,000 | +26.7% | 113,072 | +5.5% | 0.01% | 0.0% |
| Q3 2020 | $2,557,000 | +20.7% | 107,195 | +5.8% | 0.01% | +20.0% |
| Q2 2020 | $2,119,000 | +477.4% | 101,336 | +394.8% | 0.01% | +400.0% |
| Q1 2020 | $367,000 | – | 20,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EPIQ PARTNERS, LLC | 169,250 | $4,451,000 | 2.55% |
| Cornerstone Advisors, LLC | 459,157 | $12,076,000 | 1.06% |
| Matisse Capital | 250,000 | $6,574,000 | 0.95% |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 45,356 | $1,193,000 | 0.94% |
| 1607 Capital Partners, LLC | 423,925 | $11,149,000 | 0.54% |
| Thomas J. Herzfeld Advisors, Inc. | 33,722 | $887,000 | 0.40% |
| KAVAR CAPITAL PARTNERS GROUP, LLC | 39,750 | $1,045,000 | 0.28% |
| Stockman Wealth Management, Inc. | 20,296 | $534,000 | 0.15% |
| Karpus Management, Inc. | 186,631 | $4,908,000 | 0.15% |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | 100,211 | $2,631,000 | 0.14% |